Metformin: A Hopeful Promise in Aging Research
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Even though the inevitable process of aging by itself cannot be considered a disease, it is directly linked to life span and is the driving force behind all age-related diseases. It is an undisputable fact that age-associated diseases are among the leading causes of death in the world, primarily in industrialized countries. During the last several years, an intensive search of antiaging treatments has led to the discovery of a variety of drugs that promote health span and/or life extension. The biguanide compound metformin is widely used for treating people with type 2 diabetes and appears to show protection against cancer, inflammation, and age-related pathologies. Here, we summarize the recent developments about metformin use in translational aging research and discuss its role as a potential geroprotector.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The antidiabetic drug metformin, which, among other activities, inhibits the SASP, alleviates several age-related conditions and chronic diseases110–114.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [110]
In the citing paper
“Metformin, resveratrol and rapalogs (agents related to rapamycin) are SASP inhibitors and appear to impact some of the same basic processes as caloric restriction or exercise110,138.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [110]
In the citing paper
“Metformin has now been found to target several age-related pathways(3, 276, 277)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [277]
Citations
Cites
1 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M.-H., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 478
RetractedStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 3×
“The role of LKB1– AMPK as mediator of metformin’s action on hepatic gluconeogenesis and lipogenesis (Zhou et al. 2001; Zou et al. 2004; Shaw et al. 2005) was put to test in studies using conditional Ampk knockout mice (Foretz et al.”
BackgroundAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 4×
“In the latter study, metformin-mediated mGPD inhibition was accompanied by lower mitochondrial NADH/NADþ ratios, a result inconsistent with prior reports showing that complex I inhibition by metformin increased this ratio (Owen et al. 2000).”
BackgroundResultInfluentialThe Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,778
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
mTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676 · cited 1×
“Because of the many faces of mTOR in life span and metabolism, it is intriguing that metformin may act as a potential therapeutic drug for the treatment of aging and age-related diseases, such as cancer and metabolic syndrome (Johnson et al. 2013).”
Background
Cited by
Items 101–184 of 184
Delaying Renal Aging: Metformin Holds Promise as a Potential Treatment
Qiao, Z., Zhao, J., Yuan, J., Qin, Y., Zhu, Z., Liu, J., & Sun, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0168 · Cited by 13
Update of cellular senescence in kidney fibrosis: from mechanism to potential interventions
Yang, L., Ma, L., Fu, P., & Nie, J. (2025) · Frontiers of Medicine · doi:10.1007/s11684-024-1117-z · Cited by 13
Responsible biology, aging populations and the 50th anniversary of the “War on Cancer”
Farrelly, C. (2021) · Biogerontology · doi:10.1007/s10522-021-09925-y · Cited by 10
Parween, S., Rihs, S., & Flück, C. E. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105684 · Cited by 10
The NDR family of kinases: essential regulators of aging
Jonischkies, K., del Ángel, M., Demiray, Y. E., Zambrano, A. L., & Stork, O. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1371086 · Cited by 10
An Updated Prioritization of Geroscience- Guided FDA-Approved Drugs Repurposed to Target Aging
Leone, M., & Barzilai, N. (2024) · Medical Research Archives · doi:10.18103/mra.v12i2.5138 · Cited by 12
Murdocca, M., Spitalieri, P., Cappello, A., Colasuonno, F., Moreno, S., Candi, E., D’Apice, M. R., Novelli, G., & Sangiuolo, F. C. (2022) · Aging · doi:10.18632/aging.203910 · Cited by 9
Targeting the ADPKD methylome using nanoparticle-mediated combination therapy
Trinh, A., Huang, Y., Shao, H., Ram, A., Morival, J. L. P., Wang, J., Chung, E. J., & Downing, T. L. (2023) · APL Bioengineering · doi:10.1063/5.0151408 · Cited by 9
Braddock, M. (2020) · Space and society · doi:10.1007/978-3-030-42036-9_5 · Cited by 10
Rempuia, V., Anima, B., Jeremy, M., Gurusubramanian, G., Pankaj, P. P., Kharwar, R. K., & Roy, V. K. (2022) · Journal of Experimental Zoology Part A Ecological and Integrative Physiology · doi:10.1002/jez.2592 · Cited by 10
IuV, N., Klochkov, V., Kavok, N. S., Karpenko, N. A., Nikitchenko, I. V., Yefimova, S. L., & Bozhkov, A. I. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02734-x · Cited by 8
Pathogens accelerate features of human aging: A review of molecular mechanisms
Proal, A. D., & VanElzakker, M. B. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102865 · Cited by 8
Metformin as an activator of AMP-activated protein kinase. Known and new mechanisms of action
Mkrtumyan, A. M., Маркова, Т. Н., Ovchinnikova, M. A., Ivanova, I. A., & Kuzmenko, K. V. (2023) · Diabetes Mellitus · doi:10.14341/dm13044 · Cited by 8
Rim, J. G., Gallini, J. W., Jasien, C. L., Cui, X., Phillips, L., Trammell, A. W., & Sadikot, R. T. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.01.003 · Cited by 7
Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics
Garzon-Escamilla, N., Medina-Cardena, M., Roy, P., Trent, J., Jamous, J., Somesan, Y., & Denslow, S. (2026) · Biomedicines · doi:10.3390/biomedicines14020316 · Cited by 7
An Introductory Guide to Using Bloomington Drosophila Stock Center and FlyBase for Aging Research
Zheng, X. (2024) · Cells · doi:10.3390/cells13141192 · Cited by 5
Romero, M., Gelsomini, A., Miller, K., Suresh, D., Thaller, S. R., & Frasca, D. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.10.013 · Cited by 7
Механізми дії метформіну за діабету та пов’язаних із діабетом патологій
SOKOLOVA, L. K., Pushkarev, V. M., & Ковзун, О. І. (2020) · Endokrynologia · doi:10.31793/1680-1466.2020.25-2.143 · Cited by 5
“Positive Biology” and Well-Ordered Science
Farrelly, C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780197512531.003.0007 · Cited by 5
How should wetheorizeabout justice in the genomic era?
Farrelly, C. (2021) · Politics and the Life Sciences · doi:10.1017/pls.2021.3 · Cited by 7
Ashiqueali, S., Schneider, A., Zhu, X., Juszczyk, E., Mansoor, M. A. M., Zhu, Y. X., Fang, Y., Zanini, B. M., Garcia, D. N., Hayslip, N., et al. (2024) · Aging Cell · doi:10.1111/acel.14227 · Cited by 4
Regenerative Rehabilitation in Sarcopenia, Dynapenia, and Frailty
Baumann, C. W., Clark, B. C., Phillips, B. E., Szewczyk, N. J., & Consitt, L. A. (2022) · Physiology in health and disease · doi:10.1007/978-3-030-95884-8_5 · Cited by 4
Biomedicines in Longevity and Aging The Quest to Resist Biological Decline
Raymond, R. D. D. (2024) · Biomedicine · doi:10.37796/2211-8039.1433 · Cited by 4
Hinton, A. O., Jr., Neikirk, K., Han, L., Oliver, A. F., Harris, C., Martin, P., & Gaye, A. (2024) · Aging advances. · doi:10.4103/agingadv.agingadv-d-24-00011 · Cited by 4
Wissbroecker, K. B., Zmuda, A. J., Karumanchi, H., & Niehaus, T. D. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107935 · Cited by 3
Drevin, G., Leuger, L., Renard, L., Jousset, N., Malbranque, S., Dieu, X., Ferec, S., Baudriller, A., Briet, M. B., & Abbara, C. (2025) · Forensic Science International · doi:10.1016/j.forsciint.2025.112680 · Cited by 3
Kaltenmeier, C., Morocco, B., Yazdani, H. O., Reitz, K. M., Meyer, K., Molinari, M., Geller, D. A., & Tohme, S. T. (2021) · The American Surgeon · doi:10.1177/00031348211060445 · Cited by 3
Naumova, N., Koliada, A. K., Kuzub, N., & Vaiserman, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823679-6.00012-6 · Cited by 3
From mitochondria to cells to humans: Targeting bioenergetics in aging and disease
Berry, B. J., Pharaoh, G. A., & Marcinek, D. J. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106391 · Cited by 3
Взаємозв’язок між прийомом метформіну й дефіцитом вітаміну В12 у хворих на цукровий діабет 2-го типу
Pankiv, V. І. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.15.1.2019.158691 · Cited by 3
A Geroscience Approach to Preventing Pathologic Consequences of COVID-19
Dou, Y., Fatemi, S., Darvas, M., Gale, M., & Ladiges, W. (2020) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.29018.dou · Cited by 4
Aging and the Ethics of Longevity Science
Farrelly, C. (2026) · doi:10.1093/9780197830062.001.0001 · Cited by 2
Effect of Metformin on Interleukin-6 Expression in Human Fibroblast Cell Aging Model
Achadiyani, A., Prabhasiwi, D., Pratiwi, A. E., Hamudin, A., Heryaman, H., Alfarafisa, N. M., & Atik, N. (2024) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2977 · Cited by 2
Goh, K. K.-K., Sin, L.-J., Tng, D. J. H., Low, J. G. H., & Lim, T.-P. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.111882 · Cited by 2
Mechanisms and Late-Life Intervention of Aging
Goto, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-3585-3_17 · Cited by 2
Metformin Modulates the Mechanisms of Ageing
Cătoi, A. F., Andreicuț, A. D., Vodnar, D. C., Szabó, K., Corina, A., Arsene, A. L., Ștefan, S., Stoica, R. A., & Rizzo, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89431 · Cited by 2
Employing an “aging paradox” to uncover effective measures for advancing productive longevity
Preuss, H. G., Kaats, G. R., Mrvichin, N., Bagchi, D., & Aruoma, O. I. (2022) · American Journal of Biopharmacy and Pharmaceutical Sciences · doi:10.25259/ajbps_4_2022 · Cited by 2
An Updated Review on Repurposing of Metformin
Rikabi, H. A., Abdulla, D. A., & Mudawi, M. M. E. (2024) · Asian Journal of Pharmaceutical Research and Health Care · doi:10.4103/ajprhc.ajprhc_143_24 · Cited by 1
Anti-Aging Pharmacology: Advances and Prospects
Kumarachari, R. K., Bukke, S. P. N., Kammara, L., Chandrakala, A. N., Himasaila, M., & Kamati, M. (2025) · IGI Global eBooks · doi:10.4018/979-8-3693-9730-5.ch004 · Cited by 1
Seki, T., Yamanashi, T., Shimura, A., Chang, G., Santiago, T. A., Phuong, N. J., Nguyen, H. D., Gorantla, N., Nishiguchi, T., Yamanishi, K., et al. (2025) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.jaclp.2025.07.003 · Cited by 1
Metformin and incident osteoarthritis: Causal insights from a co-twin control study
Magnusson, K., Turkiewicz, A., Dell’Isola, A., Kiadaliri, A., & Englund, M. (2025) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2025.12.014 · Cited by 2
Li, L., Huang, X., & Li, P. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70188 · Cited by 1
Yenmiş, G. (2018) · AYDIN TIP FAKÜLTESİ KLİNİKLERİ DERGİSİ · doi:10.17932/iau.tfk.2018.008/2020.302/tfk_v03i2001 · Cited by 3
Sex and body composition influences the Quilombolas strength
Pereira, L. C., de Santana, F. S., Lamarca, F., Garcia, K. R., Karnikowski, M., Neto, L. S. S., Oliveira, H. B., Osório, N. B., da Silva, I. C. R., & Karnikowski, M. G. D. O. (2020) · JCSM Clinical Reports · doi:10.1002/crt2.28 · Cited by 1
Kumari, A., Neeraj, N., Yadav, A., & Pal, A. K. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns2.7582 · Cited by 1
Antiaging drugs, candidates, and food supplements: the journey so far
Yodhaanjali, J. R., Surya, R., Sumukha, K. C., Harini, G., Deshpande, G., Chandan, S. A., & Achar, R. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90235-9.00016-1 · Cited by 1
Topal, A., Mutlu, A. G., Alkan, İ., Korkmaz, D., Yıldız, H., & TIKIRDIK, M. (2023) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022310233 · Cited by 1
Yang, C. T., Katz, J. N., Selzer, F., Conley, C., Lemaster, N. G., Stone, A. V., Kumara, M. T., Matzkin, E. G., Kim, J. S., Jacobs, C. A., et al. (2025) · Orthopaedic Journal of Sports Medicine · doi:10.1177/23259671241311906 · Cited by 1
Exploring the Next Generation of Metformin Derivatives and Their Biomedical PromisePreprint
Žídek, Š., Štěpánková, K., & Lehocký, M. (2024) · Preprints.org · doi:10.20944/preprints202410.0086.v1 · Cited by 2
Aging and New Therapeutic Agents
Win, M. T. T. (2019) · Medical Journal of Clinical Trials & Case Studies · doi:10.23880/mjccs-16000201
Pharmacological Treatment for Aging: Are We There?
Barrera-Vázquez, O. S., & Gómez-Verján, J. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_12
Ghatge, A. S., Ghatge, S. B., Deshmukh, A. R., Aiholli, S., Sawle, S., & Patlola, A. (2020) · GLOBAL JOURNAL FOR RESEARCH ANALYSIS · doi:10.36106/gjra/1001020
Therapeutic approaches for the treatment of aging-induced stem cell dysfunction
Bizzaro, D., Russo, F. P., & Burra, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820071-1.00018-9
Can Metformin Downshift the Gears of Aging to Slow Emphysema Progression?
Petrache, I., & Serban, K. A. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202105-1273ed
Metformin's Potential as a Form of Anti-Aging Therapy
Kourhabi, H., Hassoun, E. E., & Hwangbo, D. (2020) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville)
Chronic Mechanistic Target of Rapamycin Inhibition: Preventing Cancer to Delay Aging or Vice Versa?
Hambright, H. G., Hurez, V. J., & Curiel, T. J. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_81
Chronic Mechanistic Target of Rapamycin Inhibition: Preventing Cancer to Delay Aging or Vice Versa?
Hambright, H. G., Hurez, V. J., & Curiel, T. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-44870-1_81-1
Youssef, H. S., Ibrahim, R., Hassan, M., Muhammad, M., & El, A. (2022) · Benha Medical Journal · doi:10.21608/bmfj.2022.141060.1598
ЛЕЧЕНИЕ CАХАРНОГО ДИАБЕТА 2 ТИПА МЕТФОРМИНОМ И МЕТАБОЛИЗМ ВИТАМИНА В12
Угли, М. А. А., Кадиржановна, Ю. Ш., & Sodikovna, A. D. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.7823283
Hypotheses on the extended phenotype of the mitochondrion: sex, mortality, and agingPreprint
Irlam, G. (2023) · EcoEvoRxiv · doi:10.32942/x2h309
Beyond the metabolic syndrome: Adverse influences of insulin resistance on the aging process
Preuss, H. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00030-x
Imagination and idealism after the COVID-19 pandemic: the science of healthy ageing
Farrelly, C. (2024) · Royal Society Open Science · doi:10.1098/rsos.231102
Changes in The Aging Cytoskeleton and How Metformin Plays a Role in Delaying Aging
Yusti, D. A., Achadiyani, A., & Khairani, A. F. (2024) · Jurnal Aisyah Jurnal Ilmu Kesehatan · doi:10.30604/jika.v9i1.2672
The transcriptome of the olm provides insights into its evolution and gene expression
Holtze, S., Demirtürk, D., Ohlenschläger, O., Hegele, S., Siniuk, K., Förste, S., Raghavan, V., Groth, M., Bens, M., Hassel, N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-10073-3
Metformin: Glycemic and Extra-Glycemic Actions
Massarini, S., & Luzi, L. (2025) · Springer eBooks · doi:10.1007/978-3-032-01700-0_10
Multi-omics analysis of the ageing liver
Kleinenkuhnen, N. (2023) · Kölner Universitäts PublikationsServer (Universität zu Köln)
ВЗАИМОСВЯЗЬ МЕЖДУ ПРИЕМОМ МЕТФОРМИНА И ДЕФИЦИТОМ ВИТАМИНА В12 У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ 2-ГО ТИПА
В.И., П. (n.d.) · CyberLeninK (CyberLeninka)
Akbar, A., Nawaz, S., Iqbal, Q. M., Ashraf, E., Mazhar, M., & Irum, B. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i12.2684
Varmazyar, T., Heidariyeh, N., & Ababzadeh, S. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102668 · Cited by 1
Medeiros, E. B., Monteiro, I. D. O., Kluwe‐Schiavon, B., Possamai, O. L., Fenilli, G. P., Keller, G. S., Lídio, A. V., Casagrande, D. D., Souza, C. S. M., Silveira, G. D. B., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11104-9 · Cited by 1
Imagination and Idealism After the COVID-19 Pandemic
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0005
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0012
Equality and the Intersectionality of Biological Aging
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0007
The Good Life as a Constraint on Longevity Science
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0010
Philosophy and the “Framing” of Translational Science
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0002
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0003
“Fair Innings,” Women, and Longevity Science
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0008
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0009
Public Health Must Transcend Folkbiology
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0006
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0011
Introduction: The Tale of the Journey Through the Ocean of Longevity
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0001
The Frankensteinification of Translational Gerontology
Farrelly, C. (2026) · Oxford University Press eBooks · doi:10.1093/9780197830062.003.0004
TREATMENT OF TYPE 2 DIABETES WITH METFORMIN
Угли, М. А. А., Кадиржановна, Ю. Ш., & Sodikovna, A. D. (2023) · Web of Medicine: Journal of Medicine, Practice and Nursing
Metadata
- Authors
- Novelle, M. G., Ali, A., Diéguez, C., Bernier, M., & de Cabo, R.
- Affiliations
- National Institutes of Health (US)
- Centro de Investigación Biomédica en Red (ES)
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-03
- Volume
- 6
- Issue
- 3
- Pages
- a025932
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC4772077
- OpenAlex
- W2289120809
- Cited by
- 178
- References
- 116
- Citations by year
- 2026: 17 · 2025: 13 · 2024: 27 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 24 · 2019: 12 · 2018: 12 · 2017: 11 · 2016: 2
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- Instituto de Salud Carlos III
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- metformin, aging, age-related diseases, healthspan, lifespan extension, type 2 diabetes, cancer protection, inflammation
- MeSH terms
- Aging, Humans, Life Expectancy, Metformin, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.